Ceramic nanoparticles: Recompense, cellular uptake and toxicity concerns

Artificial Cells, Nanomedicine and Biotechnology

Volumn 44, Issue 1, 2016, Pages 401-409

  Singh, Deependra ^a   Singh, Satpal ^a   Sahu, Jageshwari ^a   Srivastava, Shikha ^a   Singh, Manju Rawat ^a  

^a PT RAVISHANKAR SHUKLA UNIVERSITY   (India)

Author keywords

Cellular uptake; Ceramic nanocarriers; Nanoparticles; Nanosystems; Toxicity

Indexed keywords

BIOASSAY; BIODEGRADABILITY; CERAMIC MATERIALS; NANOCOMPOSITES; NANOPARTICLES; SCAFFOLDS (BIOLOGY); TOXICITY; YARN;

CELLULAR UPTAKE; CERAMIC NANOPARTICLES; DRUG DELIVERY SYSTEM; DRUG LOADING; HIGH MECHANICAL STRENGTH; NANO CLAYS; NANO-CARRIERS; TARGET CELLS;

NANOSYSTEMS;

DENDRIMER; FREE RADICAL; LIPOSOME; NANOBOT; NANOCARRIER; NANOCRYSTAL; NANOPARTICLE; NANOTUBE; SILICA NANOPARTICLE; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; ALUMINUM OXIDE; CALCIUM PHOSPHATE; DRUG CARRIER; FERRIC ION; FERRIC OXIDE; SILICON DIOXIDE; TITANIUM; TITANIUM DIOXIDE; ZIRCONIUM;

CERAMICS; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENDOCYTOSIS; NANOCLAY; NANOTECHNOLOGY; PHAGOCYTOSIS; REVIEW; CHEMISTRY; DRUG FORMULATION; HUMAN; PHARMACOKINETICS; PROCEDURES; TOXICITY;

ALUMINUM OXIDE; CALCIUM PHOSPHATES; CERAMICS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG LIBERATION; FERRIC COMPOUNDS; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; SILICON DIOXIDE; TITANIUM; ZIRCONIUM;

EID: 84964318932     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.3109/21691401.2014.955106     Document Type: Review

References (68)

1. Armatas GS, Kanatzidis MG. 2006. Mesostuctured germanium oxide with cubic pore symmetry. Nature. 441: 1122-1125.
2. Alyautdin RN, Reichel A, Lobenberg R, Ramge P, Kreuter J, Begley DJ. 2001. Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro. J Drug Target. 9: 209-221.
3. Barenholz Y. 2012. Doxil® - The first FDA-approved nano-drug: lessons learned. J Control Release. 160: 117-134.
4. Block JE, Thorn MR. 2000. Clinical indications of calcium-phosphate biomaterials and related composites for orthopedic procedures. Calcif Tissue Int. 66: 234-238.
5. Boris MH, Reichert JC, Schantz JT, Gbureck U, Rackwitz L, Nöth U, et al. 2013. How smart do biomaterials need to be? A translational science and clinical point of view. Adv Drug Del Rev. 65: 581-603.
6. Chithrani BD, Ghazani AA, Chan WCW 2006. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cell. Nano Lett. 6: 662-668.
7. Clift MJ, Rutishauser BR, Brown DM. 2008. The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line. Toxicol Appl Pharmacol. 232: 418-427.
8. LaVan DA, McGuire T, Langer R. 2003. Small scale systems for in vivo drug delivery. Nat Biotechnol. 21: 1184-1191.
9. Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A. 2002. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science. 298: 1759-1762.
10. Duncan R. 2003. The dawning era of polymer therapeutics. Nat Rev Drug Disc. 2: 347-360.
11. Duncan R. 2006. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer. 6: 688-701.
12. Farokhzad OC, Langer R. 2009. Impact of nanotechnology on drug delivery. ACS Nano. 3: 16-20.
13. Ferrari M. 2005. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5: 161-171.
14. Fubini B. 1997. Surface reactivity in the pathogenic response to particulates. Environ health perspect 105: 1013-1020.
15. Gao H, Shi W, Freund LB. 2005. Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci USA. 102: 9469-9474.
16. Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schultz H, et al. 2005. Ultrafine particles cross cellular membranes by nonphagocytotic mechanisms in lungs and in cultured cells. Environ Health Perspect. 113: 1555-1560.
17. Gash AE, Tilltson TM, Satcher JH, Hrubesh LW, Simpson RL. 2001. New sol-gel synthetic route to transition and main group metal oxide aerogels using inorganic salt precursors. J Non-cryst Solids. 285: 22-28.
18. Gladstone HB, McDermott MW, Cooke DD. 1995. Implants for cranioplasty, Otolaryngol. Clin North Am. 28: 381-400.
19. Harper S, Usenko C, Hutchison JE, Maddux BLS, Tanguay RL. 2008. In vivo biodistribution and toxicity depends on nanomaterial composition, size, surface functionalization and route of exposure. J Exp Nanosci. 3: 195-206.
20. Hrkach J, Von Hoff D, Ali MM, Andrianova E, Auer J, Campbell T, et al. 2012. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med. 4: 128-139.
21. Hussain S, Boland S, Baeza-Squiban A, Hamel R, Thomassen LC, Martens JA. 2009. Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: role of particle surface area and internalized amount. Toxicology. 260: 142-149.
22. JinJin S, Wang Z, Wang L, Wang H, Li L, Yu X, Zhang J, Ma R, Zhang Z. 2013. Photodynamic therapy of a 2-methoxyestradiol tumor-targeting drug delivery system mediated by Asn-Gly-Arg in breast cancer. Int J Nanomedicine. 8: 1551-1562.
23. Kohane DS 2007. Microparticles and nanoparticles for drug delivery. Biotechnol Bioeng. 96: 203-209.
24. Kevadiya BD, Bajaj HC. 2013. The layered silicate montmorillonite as a drug delivery. Key Eng Mat. 571: 111-132.
25. Lade M, Mays H, Schmidt J, Willumeit R, Schomacker R. 2000. On the nanoparticle synthesis in microemulsions: detailed characterization of an applied reaction mixture. Colloids Surf A Phys Chem. 163: 3-15.
26. Li X, Kanjwal MA, Lin L, Charonakis IS. 2013. Electrospun polyvinylalcohol nanofibres as oral fast-dissolving delivery system of caffeine and riboflavin. Key Eng Mat. 103: 182-188.
27. Linkov I, Satterstrom FK, Corey LM. 2008. Nanotoxicology and nano-medicine: making hard decisions. Nanomedicine Nanotech Bio Med. 4: 167-171.
28. Liu J. 2014. Hyperbranched polyether hybrid nanospheres with CdSe quantum dots incorporated for selective detection of nitric oxide. Mater Lett. 123: 104-106.
29. Lo S, Kumar A, Hsieh JT, Sun X. 2013. Dendrimers nanoscaffold for potential theranostics of prostate cancer with a focus on radiochemistry. Mol Pharm. 10: 793-812.
30. Marchant GE 2009. Small is beautiful: what can nanotechnology do for personalized medicine? Curr Pharmacogenomics Person Med. 7: 231-237.
31. Medina SH, El-Sayed Mohd EH. 2009. Dendrimers as carriers for delivery agents. Chem Rev. 109: 3141-3157.
32. Miller K, Erez R, Segal E, Shabat D, Satchi-Fainaro R. 2009. Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer-alendronate-taxane conjugate. Angew Chem Int Ed. 48: 6387-6392.
33. Muhlfeld C, Gehr P, Rothen-Rutishauser B. 2008. Translocation and cellular entering mechanisms of nanoparticles in the respiratory tract. Swiss Med Wkly. 138: 387-391.
34. Muller RH, Mader K, Gohla S. 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery a review of the state of the art. Eur J Pharm Biopharm. 50: 161-177.
35. Muller RH, Radtke M, Wissing SA. 2002. Solid lipid nanoparticles (SLN) and Nanostructured lipid carriers (NLC) in cosmetic and dermatological preparation. Adv Drug Deliv Rev. 54: 5131-5155.
36. Muro S, Schuchman EH, Muzykantov VR. 2006. Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation- and clathrin-dependent endocytosis. Mol Ther. 13: 135-141.
37. Nel AE, Madler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, et al. 2009. Understanding biophysicochemical interactions at the nanobio interface. Nat. Mater. 8: 543-557.
38. Oberdorster G. 2010. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Int Med. 267: 89-105.
39. Paveer U, Ingrid T, Lust A. 2014. Soluplus Graft copolymer: potential novel carrier polymer in electrospinning of nanofibrous drug delivery systems for wound therapy. Biomed Res Int. 2014: 789765. Article ID 789765
40. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. 2007. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2: 751-760.
41. Porter AE, Muller K, Skepper J, Midgley P, Welland M. 2006. Uptake of C60 by human monocyte macrophages, its localization and implications for toxicity: studied by high resolution electron microscopy and electron tomography. Acta Biomater. 2: 409-419.
42. Porter AE, Gass M, Muller K, Skepper JN, Midgley PA, Welland M. 2007. Direct imaging of single-walled carbon nanotubes in cells. Nat. Nanotechnol. 2: 713-717.
43. Quan CY, Chang C, Wei H, Chen CS, Xu XD, Cheng SX, et al. 2009. Dual targeting of a thermosensitive nanogel conjugated with transferrin and RGD-containing peptide for effective cell uptake and drug release. Nanotechnology. 20: 335101.
44. Rawat M, Singh D, Saraf S, Saraf S. 2006. Nanocarriers: Promising vehicle for bioactive drugs. Biol Pharm Bull. 29: 1790-1798.
45. Rawat M, Singh D, Saraf S, Saraf S. 2008. Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme. Drug Dev Ind Pharm. 34: 181-188.
46. Riman RE, Suchanek WL, Lencka MM. 2002. Hydrothermal crystallization of ceramics. Ann Chim Sci Mat. 27: 15-36.
47. Roy R, Kumar S, Tripathi A, Das M, Dwivedi PD. 2014. Interactive threats of nanoparticles to the biological system. Immunol Lett. 158: 79-87.
48. Sakamoto JH, van de Ven AL, Godin B, Blanco E, Serda RE, Grattoni A, et al. 2010. Enabling individualized therapy through nanotechnology. Pharmacol Res. 62: 57-89.
49. Sanvicens N, Marco MP. 2008. Multifunctional nanoparticles-properties and prospects for their use in human medicine. Trends Biotechnol. 26: 425-433.
50. Schins RP, Duffin R, Hohr D, Knaapen AM, Shi T, Weishaupt C, et al. 2002. Surface modification of quartz inhibits toxicity, particle uptake, and oxidative DNA damage in human lung epithelial cells. Chem Res Toxicol. 15: 1166-1173.
51. Shi J, Yu X, Wang L, Liu Y, Gao J, Zhang J, et al. 2013. PEGylated fullerene/iron oxide nanocomposites for photodynamic therapy, targeted drug delivery and MR imaging. Biomaterials. 34: 9666-9677.
52. Shibahara A, Hoshino A, Hanaki K, Suzuki K, Yamamoto K. 2004. On the cyto-toxicity caused by quantum dots. Microbiol Immunol. 48: 669-675.
53. Shvedova AA, Kagan VE, Fadeel B. 2010. Close encounters of the small kind: adverse effects of man-made materials interfacing with the nano-cosmos of biological systems. Annu Rev Pharmacol Toxicol. 50: 63-88.
54. Singh D, Dubey P, Pradhan M, Rawat M. 2013. Ceramic nanocarriers: versatile nanosystem for protein and peptide delivery. Expert Opin Drug Deliv. 10: 241-259.
55. Singer JW, Shaffer S, Baker B, Bernareggi A, Stromatt S, Nienstedt D, Besman M. 2005. Paclitaxel poliglumex (XYOTAX; CT-2103): an intracellularly targeted taxane. Anticancer Drugs. 16: 2223-228.
56. Singh S, Shi T, Duffin R, Albrecht C, van Berlo D, Hohr D, et al. 2007. Endocytosis, oxidative stress and IL-8 expression in human lung epithelial cells upon treatment with fine and ultrafine TiO2: role of the specific surface area and of surface methylation of the particles. Toxic Appl Pharmacol. 222: 141-151.
57. Stefani D, Wardman D, Lambert T. 2005. The implosion of the Calgary General Hospital: ambient air quality issues. J Air Waste Manag Assoc. 55: 52-59.
58. Suh WH, Suslick SK, Stucky Galen D, Suh YH. 2009. Nanotechnology, nanotoxicology, and neuroscience. Pro Neurobiol. 87: 133-170.
59. Ulbrich K, Subr V. 2004. Polymeric anticancer drugs with pH-controlled activation. Adv Drug Deliv Rev. 56: 1023-1050.
60. Whitters CJ, Strang R, Brown D, Clarke RL, Curtis RV, Hatton P V, et al. 1999. Dental materials: 1997 literature review. J Dent. 27: 401-435.
61. Wu C, Zreiqat H. 2010. Porous bioactive diopside (CaMgSi2O6) ceramic microspheres for drug deliver. Acta Biomater. 6: 820-829.
62. Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, et al. 2006. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 6: 1794-1807.
63. Wu X, Wu M, Zhao JX. 2014. Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy. Nanomedicine. 10: 297-312.
64. Yacobi NR, Phuleria HC, Demaio L, Liang CH, Peng CA, Sioutas C, et al. 2007. Nanoparticle effects on rat alveolar epithelial cell monolayer barrier properties. Toxicol In Vitro. 21: 1373-1381.
65. Zhang L. 2004. Preparation of multi-component ceramic nanoparticles. CISM. 8-21.
66. Zhang XQ, Xu X, Bertrand N, Pridgen E, Swami A, Farokhzad OC. 2012. Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine. Adv Drug Delivery Rev. 64: 1364-1384.
67. Zhou X, Porter LA, Robinson KRD, Shim SM, Guo Y. 2014. Nanoenabled drug delivery: a research profile. Nanomedicine. 10: 889-896.
68. Zou XD, Conradsson T, Klingstedt M, Dadachov MS, O'Keeffe M. 2005. Mesostuctured germanium oxide with crystalline pore walls and its chiral derivative. Nature. 437: 716-719.